glp 1 affect hormones can period GLP-1 medications be life-changing but there's an important conversation GLP-1, Incretin Hormones, and ADHD

Estimated two-year mortality rates with 95% confidence intervals were as follows (Figure 1): 13.1% (11.8%-14.6%) for patients prescribed both GLP-1 RA and SGLT2i 17.8% (16.6%-19.1%) for GLP-1 RA only 20.6% (19.5%-21.8%) for SGLT2i only 28.1% (27.7%-28.4%) for neither Prescription rates at the time of HF admission evolved as follows (Figure 2): January 2018: GLP-1 RA 0.9%, SGLT2i 0.5%, both 0.0%, neither 98.6% December 2024: GLP-1 RA 13.6%, SGLT2i 18.7%, both 6.3%, neither 74.0%

Vigorous agitation is avoided across peptide research generally because it can shear peptide bonds and degrade the compound before it's even used

How long after starting Semaglutide should I expect to notice a decrease in appetite

Evaluation of melanotan-II in a pilot phase-I clinical study